Together we will beat cancer

Donate

Children develop different types of cancers than adults, with around 1,900 children under the age of 14 diagnosed each year. The most common types of childhood cancer are acute leukaemia and cancers of the brain and spinal cord. Thanks to research into new treatments, 8 in 10 children diagnosed with cancer will live for at least five years.

The Nobel Prize winner helping us treat children’s cancers

Professor Carolyn Bertozzi won the 2022 Nobel Prize in Chemistry. She’s using all she’s learned to create better treatments for solid tumours in children.

Read More

Changes to chromosomes impact how children’s brain tumours respond to treatment

Our scientists have found tiny cellular changes that make medulloblastomas resistant to treatment. Understanding them could help us treat the disease in future.

Read More

Banking on breakthroughs for children and young people

A newly merged biobank will be UK’s leading biomedical research resource dedicated to storing samples and data of cancers in children and young people – we explore its potential impact…

Read More

Life beyond cancer: Improving the long term side effects for children and young people with brain cancer

We spoke to Dr Debbie Hicks about what is being done to understand and minimise the impact of long-term side effects for children and young people with medulloblastoma.

Read More

The link between Down syndrome and childhood leukaemia

In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery.

Read More

Inside Cancer Grand Challenges Part 1: what makes a grand challenge?

This entry is part 1 of 2 in the series Inside Cancer Grand Challenges

Today, Cancer Grand Challenges announced four new teams that have each received £20 million in funding to take on the biggest challenges in cancer research

Read More

Childhood cancer survivors at greater risk of ill health

People who survive cancer in childhood have a higher risk of ill health as they grow older, according to new research published in The Lancet Regional Health – Europe.

Read More

Sustainability a major focus of our 17th year partnering with TK Maxx

In 2004, we joined forces with TK Maxx to raise awareness and funds for children’s and young people’s cancers. Since…

Read More

Black in Cancer – That Cancer Conversation

This entry is part 3 of 5 in the series That Cancer Conversation

From groundbreaking rare cancer research to ending up on Forbes 30 under 30, we chat to Sigourney Bell about her work in the lab and her global organisation, Black in Cancer.

Read More

Delivering the future of paediatric brain tumour therapy

Dr Lisa Ruff tells us why drug delivery is so important for the treatment of paediatric brain tumours – and why hydrogels could be key to a breakthrough…

Read More